medigraphic.com

2016, Number S2

<< Back Next >>

Rev Mex Anest 2016; 39 (S2)

Critical obstetric hemorrhage: Alternatives to transfusional medicine

Pérez-Calatayud ÁA, Anica-Malagón ED, Zavala-Barrios B, Montesinos PNE, Méndez-Arreguín AD, Briones-Garduño JC

Language: Spanish
References: 39
Page: 313-318
PDF size: 189.73 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Abdul-Kadir R, McLintock C, Ducloy AS, El-Refaey H, England A, Federici AB. Evaluation and management of postpartum hemorrhage: consensus from an international expert panel. Transfusion. 2014;54:1756-1768.

  2. Centro Nacional de Excelencias en Tecnologías en salud Guía de Práctica Clínica Diagnóstico y Tratamiento de la hemorragia obstétrica en la Segunda Mitad del Embarazo y Puerperio Inmediato IMSS-162-209.

  3. Clark V, Waters JH. Blood transfusions: more is not necessarily better. Int J Obstet Anesth. 2009;18:299-301.

  4. Dupont C, Touzet S, Colin C, et al. Incidence and management of postpartum haemorrhage following the dissemination of guidelines in a network of 16 maternity units in France. Int J Obstet Anesth. 2009;18:320-327.

  5. Sisak K, Manolis M, Hardy BM, et al. Acute transfusion practice during trauma resuscitation: Who, when, where and why? Injury. 2013;44:581-586.

  6. Hardy JF, De Moerloose P, Samama M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 2004;51:293-310.

  7. Eberst ME, Berkowitz LR. Hemostasis in renal disease: pathophysiology and management. Am J Med. 1994;96:168-179.

  8. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost. 2006;32:32-38.

  9. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360-365.

  10. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang. 2009;96:111-118.

  11. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46:685-686.

  12. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol. 2009;22:267-274.

  13. Hossain N, Paidas MJ. Disseminated intravascular coagulation. Semin Perinatol. 2013;37:257-266.

  14. Annecke T, Geisenberger T, Kürzl R, Penning R, Heindl B. Algorithm-based coagulation management of catastrophic amniotic fluid embolism. Blood Coagul Fibrinolysis. 2010;21:95-100.

  15. Carroll RC, Craft RM, Langdon RJ, et al. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res. 2009;154:34-39.

  16. Pérez-Calatayud ÁA, Briones-Garduño JC, Rojas-Arellano ML. Use of thromboelastography and thromboelastometry for the rational and opportune transfusion of hemoderivatives in obstetric hemorrhage. Ginecol Obstet Mex. 2015;83:569-577.

  17. Collins PW, Lilley G, Bruynseels D, Laurent DB, Cannings-John R, Precious E, et al. Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study. Blood. 2014;124:1727-1736.

  18. De Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv. 2012;67:426-435.

  19. Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost. 2009;101:755-761.

  20. Kreuz W, Meili E, Peter-Salonen K, et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci. 2005;32:239-246.

  21. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326-1331.

  22. Nielsen VG, Levy JH. Fibrinogen and bleeding: old molecule new-ideas. Anesth Analg. 2007;105:902-903.

  23. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5:266-273.

  24. Fenger-Eriksen C, Ingerslev J, Sorensen B, Sørensen B. Fibrinogen concentrate a potential universal hemostatic agent. Expert Opin Biol Ther. 2009;9:1325-1333.

  25. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108:984-989.

  26. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion-transmitted infection. Haematologica. 2007;92:846-849.

  27. Rahe-Meyer N, Solomon C, Winterhalter M, et al. Thromboelastometry-

  28. guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg. 2009;138:694-702.

  29. Kozek-Langenecker S, Sørensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15:R239.

  30. Makino S, Takeda S, Kobayashi T, Murakami M, Kubo T, Hata T, et al. National survey of fibrinogen concentrate usage for post-partum hemorrhage in Japan: investigated by the Perinatology Committee, Japan Society of Obstetrics and Gynecology. J Obstet Gynaecol Res. 2015;41:1155-1160.

  31. Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anesthesiol. 2008;25:784-789.

  32. Liumbruno G, Bernnardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates. Blood Transfus. 2009;7:325-334.

  33. Kor DJ, Stubbs JR, Gajic O. Perioperative coagulation management fresh frozen plasma. Best Pract Res Clin Anesthesiol. 2010;24:51-64.

  34. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost. 2003;29:125-130.

  35. Pacheco LD, Saade GR, Gei AF, Hankins GD V. Cutting edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol. 2011;205:526-532.

  36. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999;57:1005-1032.

  37. Peitsidis P, Kadir RA. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011;12:503-516.

  38. Shakur H, Elbourne D, Gülmezoglu M, Alfirevic Z, Ronsmans C, Allen E, et al. Study protocol The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:1-14.

  39. WHO Guidelines Approved by the Guidelines Review Committee. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva, Switzerland: WHO Press; 2012. [Online] Available in: http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf?ua=1




2020     |     www.medigraphic.com